Expressions of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Gastric Ischemia-Reperfusion: Role of Angiotensin II

Journal of Surgical Research

Volumn 161, Issue 1, 2010, Pages 126-133

  Gemici, Burcu ^a   Tan, Ruken ^a   Öngüt, Gözde ^a   Nimet Izgut Uysal V ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

angiotensin II; candesartan; captopril; COX 2; iNOS; ischemia reperfusion; PD123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; C 4042; CANDESARTAN; CAPTOPRIL; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CELIAC ARTERY; CONTROLLED STUDY; DRUG MECHANISM; ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; STOMACH ISCHEMIA; STOMACH MUCOSA; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; CAPTOPRIL; CYCLOOXYGENASE 2; DINOPROSTONE; GASTRITIS; IMIDAZOLES; MALE; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; REPERFUSION INJURY; TETRAZOLES;

EID: 77951621873     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.07.018     Document Type: Article

References (47)

1. Dubin A., Estenssoro E., Murias G., et al. Effects of hemorrhage on gastrointestinal oxygenation. Intensive Care Med 27 (2001) 1931 Epub 2001 Nov 10
2. Qiao W.L., Wang L., Zhang Y.M., et al. Extracellular signal-regulated kinase 1- and 2-mediated gastric mucosal injury and repair in gastric ischemia-reperfusion of rats. J Gastroenterol 41 (2006) 1158 Epub 2007 Feb 6
3. El Eter E., Al Tuwaijiri A., Hagar H., et al. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 22 (2007) 1791
4. Derin N., Izgut-Uysal V.N., Agac A., et al. L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J Physiol Pharmacol 55 (2004) 595
5. Sínay L., Kürthy M., Horváth S., et al. Ischemic postconditioning reduces peroxide formation, cytokine expression and leukocyte activation in reperfusion injury after abdominal aortic surgery in rat model. Clin Hemorheol Microcirc (2008) 40133
6. Gute D.C., Ishida T., Yarimizu K., et al. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179 (1998) 169
7. Zheng Z., and Yenari M.A. Post-ischemic inflammation molecular mechanisms and therapeutic implications. Neurol Res 26 (2004) 884
8. Riaz A.A., Wang Y., Schramm R., et al. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 18 (2004) 881
9. Takagi T., Yoshida N., Isozaki Y., et al. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Eur J Pharmacol 535 (2006) 283
10. Derin N., Agac A., Bayram Z., et al. Effects of L-carnitine on neutrophil-mediated ischemia-reperfusion injury in rat stomach. Cell Biochem Funct 24 (2006) 437
11. Suzuki Y., Ruiz-Ortega M., Lorenzo O., et al. Inflammation and angiotensin II. Int J Biochem Cell Biol 35 (2003) 881
12. Ruiz-Ortega M., Lorenzo O., Suzuki Y., et al. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10 (2001) 321
13. Marchesi C., Paradis P., and Schiffrin E.L. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 29 (2008) 367 Epub 2008 Jun 23
14. Brzozowski T., Konturek P.C., Pajdo R., et al. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J Physiol Pharmacol 59 Suppl. 2 (2008) 89
15. Suzuki Y., Ruiz-Ortega M., and EgidoAngiotensin II J. A double-edged sword in inflammation. J Nephrol 3 Suppl (2000) S101
16. Cerqueira N.F., Hussni C.A., and Yoshida W.B. Pathophysiology of mesenteric ischemia/reperfusion: A review. Acta Cir Bras 20 (2005) 336 Epub 2005 Jul 18
17. El Eter E., Hagar H.H., Al-Tuwaijiri A., et al. Nuclear factor-κB inhibition by pyrrolidine dithiocarbamate attenuates gastric ischemia-reperfusion injury in rats. Can J Physiol Pharmacol 83 (2005) 483
18. Zhang Y.M., Wei E.Q., Hu X., et al. The role of nuclear factor-κB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats. J Gastroenterol 43 (2008) 687 Epub 2008 Sep 20
19. Bülbül M., Tan R., Gemici B., et al. Effect of orexin-a on ischemia-reperfusion-induced gastric damage in rats. J Gastroenterol 43 (2008) 202
20. Baldus S., Eiserich J.P., Mani A., et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108 (2001) 1759
21. Carlton P.S., Gopalakrishnan R., Gupta A., et al. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res 62 (2002) 4376
22. Bories P.N., and Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41 6 Pt 1 (1995) 904
23. Zhong C., Zhou Y., and Liu H. Nuclear factor κB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology 100 (2004) 540
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248
25. De Gusmao F.M., Becker C., Carvalho M.H., et al. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: Effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction. Int J Cardiol 100 (2005) 363
26. Lu Y.T., Hellewell P.G., and Evans T.W. Ischemia-reperfusion lung injury: Contribution of ischemia, neutrophils, and hydrostatic pressure. Am J Physiol 273 1 Pt 1 (1997) L46
27. Hayashi Y., Sawa Y., Nishimura M., et al. Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response. Eur J Cardiothorac Surg 26 (2004) 276
28. Brzozowski T., Konturek P.C., Konturek S.J., et al. Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress. J Physiol Paris 94 (2000) 83
29. Kishimoto Y., Wada K., Nakamoto K., et al. Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats. Arch Biochem Biophys 352 (1998) 153
30. Kishimoto Y., Wada K., Nakamoto K., et al. Quantitative analysis of cyclooxygenase-2 gene expression on acute gastric injury induced by ischemia-reperfusion in rats. Life Sci 60 (1997) PL127
31. Bregonzio C., Armando I., Ando H., et al. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 285 (2003) G414
32. Zhang M.Z., Yao B., Cheng H.F., et al. Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors. Proc Natl Acad Sci U S A 103 (2006) 16045
33. Ko J.K., and Cho C.H. Co-regulation of mucosal nitric oxide and prostaglandin in gastric adaptive cytoprotection. Inflamm Res 48 (1999) 471
34. Franco L., Talamini G., Carra G., et al. Expression of COX-1, COX-2, and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection. Prostaglandins Other Lipid Mediat 58 (1999) 9
35. Salvemini D., Misko T.P., Masferrer J.L., et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90 (1993) 7240
36. Masferrer J.L., Zweifel B.S., Colburn S.M., et al. The role of cyclooxygenase-2 in inflammation. Am J Ther 2 (1995) 607
37. Whittle B.J., Lopez-Belmonte J., and Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 99 (1990) 607
38. Goodwin D.C., Gunther M.R., Hsi L.C., et al. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J Biol Chem 273 (1998) 8903
39. Gunther M.R., Hsi L.C., Curtis J.F., et al. Nitric oxide trapping of the tyrosyl radical of prostaglandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation. J Biol Chem 272 (1997) 17086
40. Kim H., and Hwan Kim K. Role of nitric oxide and mucus in ischemia/reperfusion-induced gastric mucosal injury in rats. Pharmacology 62 (2001) 200
41. Konturek P.C., Brzozowski T., Walter B., et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 536 (2006) 171
42. Nilakantan V., Hilton G., Maenpaa C., et al. Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury. Mol Cell Biochem 304 (2007) 1
43. Jugdutt B.I. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev 7 (2002) 391
44. Barsotti A., Di Napoli P., Taccardi A.A., et al. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: Evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis 155 (2001) 53
45. Kobayashi N., Nishikimi T., Horinaka S., et al. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats. Atherosclerosis 156 (2001) 255
46. Yamakawa H., Jezova M., Ando H., et al. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23 (2003) 371
47. Thai H., Wollmuth J., Goldman S., et al. Angiotensin subtype 1 Receptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther 307 (2003) 1171 Epub 2003 Oct 14